PharmaCyte Biotech (PMCBD) Stock Chart & Stock Price History $1.01 -0.01 (-0.99%) As of 06/13/2025 Add Compare Share Share Chart Stock AnalysisChartBuy This Stock PharmaCyte Biotech Stock Price Performance The PharmaCyte Biotech (PMCBD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.50%, with a year-to-date return of -34.84%. In the past month, the stock has decreased 3.81%, reflecting recent market activity. As of the latest close, PharmaCyte Biotech traded at $1.02 with a market cap of $1.71 million and volume of 9,051 shares. Receive PMCBD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.98%1 Month Performance-3.81%3 Month Performance-39.52%Year-To-Date Performance-34.84%1 Year Performance-54.50% PMCBD Stock Chart for Saturday, June, 14, 2025 PMCBD Chart by TradingView PharmaCyte Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$1.08$1.02-5.55%$1.13$1.019,051 shs$1.71 million06/12/2025$1.08$1.08$1.10$1.056,731 shs$1.81 million06/11/2025$1.04$1.08+3.85%$1.08$1.065,150 shs$1.81 million06/10/2025$1.02$1.04+1.96%$1.06$1.0314,473 shs$1.74 million06/09/2025$1.02$1.02$1.12$1.0016,544 shs$1.70 million06/06/2025$1.10$1.12+1.36%$1.14$1.119,682 shs$1.86 million06/05/2025$1.10$1.10$1.12$1.078,256 shs$1.84 million06/04/2025$1.07$1.10+2.80%$1.12$1.078,256 shs$1.84 million06/03/2025$1.03$1.07+4.35%$1.09$1.015,651 shs$1.79 million06/02/2025$1.03$1.03$1.14$1.004,478 shs$1.71 million Get the Latest News and Ratings for PMCBD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$1.07$1.03-3.74%$1.05$1.011,994 shs$1.72 million05/29/2025$1.01$1.07+5.92%$1.08$1.0022,544 shs$1.79 million05/28/2025$1.05$1.01-3.79%$1.12$1.0127,598 shs$1.69 million05/27/2025$1.05$1.05$1.05$1.019,957 shs$1.76 million05/26/2025$1.05$1.05$1.05$1.019,957 shs$1.76 million05/23/2025$1.04$1.02-2.06%$1.07$1.0113,811 shs$1.70 million05/22/2025$1.06$1.04-1.75%$1.10$1.043,240 shs$1.74 million05/21/2025$1.06$1.06$1.10$1.0410,842 shs$1.77 million05/20/2025$1.06$1.06$1.10$1.0410,842 shs$1.77 million05/19/2025$1.06$1.06$1.10$1.0410,842 shs$1.77 million05/16/2025$1.05$1.04-0.48%$1.08$1.014,563 shs$1.74 million05/15/2025$1.05$1.05-0.48%$1.06$1.0017,659 shs$1.75 million05/14/2025$1.06$1.05-0.67%$1.08$1.054,460 shs$1.76 million05/13/2025$1.11$1.06-4.77%$1.17$1.0510,244 shs$1.77 million Related Companies CHRO Stock Price Chart CVM Stock Price Chart PMCB Stock Price Chart OMGA Stock Price Chart ENZN Stock Price Chart KLTO Stock Price Chart AIM Stock Price Chart ALBT Stock Price Chart CELZ Stock Price Chart FRTX Stock Price Chart Receive PMCBD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PMCBD) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCyte Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
